Santos Esteban 4

4 · AMGEN INC · Filed May 7, 2026

AI-generated summary of this filing

Updated May 8, 2026

Amgen (AMGN) EVP Santos Esteban Receives RSUs & Option Grant

What Happened

Santos Esteban, EVP, Operations at Amgen, was granted equity awards on 2026-05-05: 2,730 restricted stock units (RSUs) and a derivative grant of 17,814 non-qualified stock options with an exercise price of $329.59 (grant valued at ~$5,871,316). On 2026-05-06, 427 shares were surrendered/withheld at $329.59 each to cover tax liabilities (cash value $140,735).
These transactions are awards/grants (not open-market purchases or sales); the 427-share disposition is a routine tax withholding.

Key Details

Transaction dates and prices:
- 5/05/2026: RSU grant — 2,730 shares @ $0.00 (acquired).
- 5/05/2026: Option grant (derivative) — 17,814 shares @ $329.59 (acquired; reported value ~$5,871,316).
- 5/06/2026: Tax withholding/payment — 427 shares @ $329.59 (disposed; $140,735).
Vesting and payout notes:
- RSUs vest in four equal annual installments (25%/year) beginning 5/5/2027; vested RSUs paid 1-for-1 in common stock (F1).
- 388 Dividend Equivalents (DEs) are included with the RSUs and pay out as shares per the vesting schedule (F2).
- The option grant vests and becomes exercisable in four equal annual installments starting 5/5/2027 (F3).
Shares owned after the transaction: not disclosed in this filing.
Filing timeliness: Report filed 2026-05-07 for transactions dated 5/05–5/06/2026; appears timely (filed within the normal 2-business-day window).

Context

This filing reflects equity compensation grants (standard executive awards) rather than a market purchase or a sell for investment purposes. The 427-share disposition was for tax withholding (common practice when RSUs/options are granted or vest), not an open-market sale indicating a change in investment stance.

Form 4

Period: 2026-05-05

EVP, Operations

Transactions

Award
Common Stock
[F1]
2026-05-05+2,730→ 83,796 total
Tax Payment
Common Stock
[F2]
2026-05-06$329.59/sh−427$140,735→ 83,369 total
Award
Nqso (Right to Buy)
[F3]
2026-05-05$329.59/sh+17,814$5,871,316→ 17,814 total
Exercise: $329.59From: 2027-05-05Exp: 2036-05-05→ Common Stock (17,814 underlying)

Holdings

Footnotes (3)

[F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
[F2]These shares include 388 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
[F3]These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.

Signature

/s/ Esteban Santos|2026-05-06

1 file